Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Contingent Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Contingent Liabilities ₹89 Cr₹92 Cr₹72 Cr₹61 Cr₹0.34 Cr

What is the latest Contingent Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Contingent Liabilities ratio of NATH BIOGENES (INDIA) is ₹89 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹89 Cr
Mar2024₹92 Cr
Mar2023₹72 Cr
Mar2022₹61 Cr
Mar2013₹0.34 Cr

How is Contingent Liabilities of NATH BIOGENES (INDIA) Trending?

Years Contingent Liabilities % Change
Mar2025 ₹89 Cr
-3.34
Mar2024 ₹92 Cr
28.60
Mar2023 ₹72 Cr
18.58
Mar2022 ₹61 Cr
17,668.04
Mar2013 ₹0.34 Cr -

Compare Contingent Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹301.3 Cr -4.5% -7.8% -8.3% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,989.8 Cr 1.1% -9.5% -24.8% Stock Analytics
KAVERI SEED COMPANY ₹5,250.4 Cr -4.6% -4% 21.7% Stock Analytics
VENKYS (INDIA) ₹1,873.3 Cr -1.7% -8.9% -20.8% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,167.3 Cr -4.3% -10.7% -22.8% Stock Analytics
INDO US BIOTECH ₹253.1 Cr 1.9% -3.4% -47.6% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-4.5%

-7.8%

-8.3%

SENSEX

0.8%

1%

9.9%


You may also like the below Video Courses